Trulieve Cannabis Corp. quarterly report, Q1 FY2025

Business Context and Reporting Period

Company: Trulieve Cannabis Corp.
Filing Type: Form 10-Q (Unaudited)
Reporting Period: Three months ended March 31, 2025
Business Overview: Trulieve is a vertically integrated, multi-state cannabis operator with retail, cultivation, and processing facilities in nine U.S. states. As of March 31, 2025, the company operated 229 dispensaries and 15 cultivation/processing facilities. The company is headquartered in Quincy, Florida, and operates under a regional hub strategy (Southeast, Northeast, Southwest).

Key Financial Metrics

Metric (in thousands) Q1 2025 Q1 2024
Revenue $297,760 $297,619
Gross Profit $183,219 $173,802
Gross Margin 61.5% 58.4%
Operating Income $33,326 $46,100
Net Loss (GAAP) $(33,759) $(24,847)
Adjusted EBITDA (Non-GAAP) $109,190 $105,795
Cash and Cash Equivalents $328,452 $320,313
Total Debt (Long-term + Current) $617,021 $621,727
Operating Cash Flow $50,736 $139,154

Note: Total Debt includes Private Placement Notes ($365.3M), Notes Payable ($111.1M), and Construction Finance Liabilities ($137.2M) as of March 31, 2025.

Material Changes vs. Prior Period

  • Revenue Stability: Revenue remained flat at approximately $297.8 million, driven by a $3.2 million increase in wholesale revenue offset by a $3.0 million decrease in retail revenue due to price compression and loyalty point redemptions.
  • Margin Expansion: Gross margin improved to 61.5% from 58.4% year-over-year, attributed to at-scale cost efficiencies and disciplined promotional activity.
  • Expense Growth: Selling, General, and Administrative (SG&A) expenses increased 17% to $118.8 million, primarily due to $13.7 million in campaign and political contributions and the addition of new dispensaries.
  • Operating Income Decline: Operating income decreased 28% to $33.3 million, largely due to the significant increase in SG&A expenses.
  • Cash Flow Volatility: Operating cash flow decreased significantly to $50.7 million from $139.2 million in Q1 2024. The prior year included a one-time $50.0 million tax refund related to amended returns under IRC Section 280E, which was not present in the current period.
  • Inventory Build: Inventories increased by $7.9 million to $239.3 million, reflecting a shift from inventory drawdown in the prior year to accumulation in the current period.

Guidance, Outlook, and Risks

  • Outlook: Management believes existing cash balances ($328.5 million) are sufficient to meet requirements for the next 12 months. The company continues to invest in infrastructure, technology, and market expansion.
  • Recent Developments: In February 2025, the company launched "Onward," a line of premium THC beverages. Subsequent to the quarter-end, the company received $7.9 million in cash from a partial insurance settlement.
  • Tax Position: The company maintains a significant uncertain tax position liability of $500.9 million, primarily related to the deductibility of business expenses under IRC Section 280E. The company recorded a $52.5 million provision for income taxes in Q1 2025.
  • Risks: Key risks include the continued illegality of cannabis under U.S. federal law (risk of asset forfeiture), intense competition, regulatory changes, and the potential for unfavorable outcomes in ongoing tax examinations.

Investor Verification Checklist

  • Tax Liability Exposure: Verify the status of the $500.9 million uncertain tax position liability and the company's ongoing legal stance regarding IRC Section 280E deductions.
  • Political Contributions: Review the impact of the $13.7 million increase in campaign and political contributions on future SG&A trends and cash flow.
  • Debt Maturities: Assess the $368 million in Private Placement Notes maturing in October 2026 and the company's refinancing or repayment strategy.
  • Inventory Valuation: Monitor the $239.3 million inventory balance for potential impairment risks given the competitive pricing environment.
  • Insurance Settlements: Track the timing and total value of the remaining insurance settlement proceeds mentioned in subsequent events.
Disclaimer:
This AI-generated summary by MetaQuotes is based on SEC filings and may contain errors. Verify important details against the original SEC filings.